STEMCELL Scaling Reagents for BC Cancer, UBC, and BCCDC COVID-19 Research Program

STEMCELL Technologies is helping to formulate reagents at scale for collaborative COVID-19 study

05/22/2020
STEMCELL Scaling Reagents for BC Cancer, UBC, and BCCDC COVID-19 Research Program
In a recent interview with BC Cancer Research, Dr. Martin Hirst, Senior Scientist at Canada's Michael Smith Genome Sciences Centre at BC Cancer (GSC), discusses the details of a multi-partner COVID-19 research project involving BC Cancer, the University of British Columbia, and the British Columbia Centre for Disease Control. Dr. Hirst highlights how STEMCELL Technologies is helping to formulate and scale reagents to support the project goals for rapid diagnostic testing.

Read More >

Image source: BC Cancer

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.